Ovarian Cancer Trial, Recruiting NCT00539162 Sponsor: M.D. Anderson Cancer Center Condition: Ovarian Cancer
Back to Ovarian Cancer

Ovarian Cancer Trial, Recruiting

NCT00539162
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a woman aged 50 to 74 years old at the time of joining the trial
  • You have gone through menopause, meaning you have had no periods for 12 months or more
  • You still have at least one ovary
  • You are currently cancer-free and have not had chemotherapy or radiation treatment in the past 12 months or more
  • You are willing to come back for an annual CA-125 blood test (a blood test that can help detect certain conditions)
  • You are willing to have a transvaginal ultrasound (an internal scan) if the trial team asks you to
  • You can provide the name of a gynaecologist or suitable healthcare professional who can give you follow-up care if needed

Who may not be able to join:

  • You are younger than 50 or older than 75 years of age
  • You have a psychiatric, psychological, or other condition that would prevent you from fully understanding and agreeing to take part
  • You have had both ovaries removed
  • You currently have an active cancer that is not ovarian cancer
  • You have a history of cancer (other than ovarian) and have received treatment within the last 12 months — though exceptions may apply for certain skin cancers or if you are taking specific hormone-related medications (confirm with trial site)
  • You are considered at high risk for ovarian cancer because of a strong family history, such as carrying a known BRCA1 or BRCA2 gene mutation, or having multiple close relatives with ovarian or breast cancer — full details of what counts as "high risk" should be confirmed with the trial site
  • You have or are a known or suspected carrier of a hereditary condition called Lynch Syndrome (also known as HNPCC), which increases cancer risk (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Denise Nebgen, MD, PHD, M.D. Anderson Cancer Center

Phone: 713-563-1790

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
2 July 2001
Est. completion
30 November 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Rate of increase in CA 125 levels and other tumor markers over time

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov